Phreesia, Inc. (PHR) |
| 12.15 0.29 (2.45%) 08-28 16:00 |
| Open: | 11.8 |
| High: | 12.295 |
| Low: | 11.8 |
| Volume: | 508,617 |
| Market Cap: | 751(M) |
| PE Ratio: | 43.39 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 15.20 |
| Resistance 1: | 13.01 |
| Pivot price: | 11.99 |
| Support 1: | 11.26 |
| Support 2: | 10.17 |
| 52w High: | 31.83 |
| 52w Low: | 7.77 |
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
| EPS | 0.160 |
| Book Value | 5.810 |
| PEG Ratio | 0.00 |
| Gross Profit | 5.439 |
| Profit Margin (%) | 1.85 |
| Operating Margin (%) | 5.15 |
| Return on Assets (ttm) | 1.5 |
| Return on Equity (ttm) | 2.9 |
Thu, 27 Aug 2026
Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Stockholders to Connect - ACCESS Newswire
Mon, 17 Aug 2026
Phreesia (NYSE: PHR) executive has 182 RSU shares withheld - Stock Titan
Tue, 11 Aug 2026
Phreesia, Inc. (PHR): Growth Potential and Analyst Consensus for This Healthcare SaaS Innovator - DirectorsTalk Interviews
Tue, 04 Aug 2026
PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: - GlobeNewswire
Mon, 03 Aug 2026
Phreesia (PHR) director takes 685 deferred stock units over cash - Stock Titan
Tue, 21 Jul 2026
Should Value Investors Buy Phreesia (PHR) Stock? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |